API

  • Cyanotis Arachnoidea weputara Beta-Ecdysterone ntụ ntụ 20-Hydroxyecdysone

    Cyanotis Arachnoidea weputara Beta-Ecdysterone ntụ ntụ 20-Hydroxyecdysone

    Ecdysteron sitere na wepụ Cyanotis arachnoidea CB Clarke. Dị ka ịdị ọcha dị iche iche, enwere ike kewaa ya n'ime ọcha, isi awọ ọcha, odo odo ma ọ bụ ìhè aja aja crystalline ntụ ntụ. industries.Hande Bio na-enye Cyanotis Arachnoidea Extract Beta-Ecdysterone Powder 20-Hydroxyecdysone. Maka nkọwa ndị ọzọ, biko kpọtụrụ online.

  • Pharmaceutical API 99% Docetaxel CAS 114977-28-5 Docetaxel maka Anticancer

    Pharmaceutical API 99% Docetaxel CAS 114977-28-5 Docetaxel maka Anticancer

    Docetaxel bụ API semi-synthetic, yana ọgbọ nke abụọ mgbochi kansa API nwetara site na ọkara njikọ nke 10-DAB.Ntinye uche intracellular nke docetaxel dị okpukpu 3 dị elu karịa nke paclitaxel, na oge njigide intracellular dị ogologo, ya mere ọ nwere ọrụ antitumor siri ike karịa paclitaxel.Hande Bio bụ onye nrụpụta docetaxel ọkachamara na onye na-ebubata ya, na-enye Pharmaceutical API 99% Docetaxel CAS 114977-28-5 Docetaxel maka Anticancer.Maka nkọwa ndị ọzọ, biko kpọtụrụ anyị n'ịntanetị.

  • Cabazitaxel CAS 183133-96-2 ntụ ntụ ọgwụ Cabazitaxel Anti-Cancer Raw ntụ ntụ

    Cabazitaxel CAS 183133-96-2 ntụ ntụ ọgwụ Cabazitaxel Anti-Cancer Raw ntụ ntụ

    Cabazitaxel bụ API mgbochi tumor.Nnwale ụlọ ọgwụ egosila na ọ nwekwara ike ibelata etuto ahụ, belata uto ma ọ bụ mgbasa nke etuto ahụ, belata ihe mgbaàmà nke ọrịa kansa prostate ma melite ogo ndụ ndị ọrịa.Cabazitaxel na ngwakọta na prednisone maka ọgwụgwọ nke hormone-refractory metastatic prostate cancer na mbụ ejiri usoro nwere docetaxel.Hand Bio na-enye Cabazitaxel CAS 183133-96-2 Pharmaceutical Powder Cabazitaxel Anti-Cancer Raw Powder.Maka nkọwa ndị ọzọ, biko nweere onwe gị ịkpọtụrụ n'ịntanetị.

  • Ihe nrụpụta 10-DAB Semi-Synthetic Paclitaxel CAS 33069-62-4 Paclitaxel API

    Ihe nrụpụta 10-DAB Semi-Synthetic Paclitaxel CAS 33069-62-4 Paclitaxel API

    Alaka na akwụkwọ nke genus Taxaceae nwere ike nweta agbụ n'akụkụ Paclitaxel (nke a na-emepụta site na usoro ihe nkedo nke 10DAB) n'oge nhazi nke mbụ.Hande Bio na-enye 10-DAB Semi-Synthetic Paclitaxel CAS 33069-62-4 Paclitaxel API.N'ihi na ihe ndị ọzọ. nkọwa, biko kpọtụrụ anyị online.

  • Ụlọ ọrụ na-eweta ihe ntụ ntụ ntụ ntụ CAS 33069-62-4 Natural Paclitaxel

    Ụlọ ọrụ na-eweta ihe ntụ ntụ ntụ ntụ CAS 33069-62-4 Natural Paclitaxel

    Isi ngwaahịa Yunnan Hande na mpaghara ọgwụ bụ paclitaxel ọgwụ akụrụngwa.E rerela paclitaxel eke Hande nke ọma n'ọtụtụ mba na mpaghara dị na North America, Europe na Asia, na-aghọ ụlọ ọrụ na-anọchite anya ụlọ ọrụ ahụ.Hande Biotech na-enye Natural Raw Material Powder CAS 33069-62-4 Natural Paclitaxel.Maka nkọwa ndị ọzọ, biko kpọtụrụ online.

  • API CRO CDMO ọrụ nka

    API CRO CDMO ọrụ nka

    Hande Bio bụ onye nrụpụta ntụkwasị obi nke na-emepụta ihe ọkụkụ, akụrụngwa ọgwụ na etiti.Hande eguzobela otu ọkachamara R&D ma nwee ụlọ ọrụ pilot GMP, nke nwere ike mee ka usoro azụmaahịa nke mmepụta na nyocha dịkwuo ngwa, na-agbakọ data usoro nke ihe nnwale, ma belata usoro mmepe.

  • Ọrụ mpụpụ API R&D API CRO

    Ọrụ mpụpụ API R&D API CRO

    Hande CDMO ọrụ maka ndị intermediates edebanyere aha na API, Hande Bio nwere 2 GMP mmepụta bases, nke izute Class A àgwà ọkọlọtọ mmepụta osisi, na melite a "3+1 ahaziri consulting otu" maka R & D, àgwà, mmepụta, na oru ngo consulting ka. ijikọ ọnụ chọta usoro mmepe ngwaahịa kacha mma.

  • API CDMO ndị na-emepụta ọgwụ API

    API CDMO ndị na-emepụta ọgwụ API

    Hande Bio bụ onye nrụpụta ntụkwasị obi nke na-emepụta ihe ọkụkụ, akụrụngwa ọgwụ na etiti.Hande eguzobela otu ọkachamara R&D ma nwee ụlọ ọrụ pilot GMP, nke nwere ike mee ka usoro azụmaahịa nke mmepụta na nyocha dịkwuo ngwa, na-agbakọ data usoro nke ihe nnwale, ma belata usoro mmepe.

  • Ndị na-eweta API nrụpụta CDMO

    Ndị na-eweta API nrụpụta CDMO

    Hande Bio bụ onye nrụpụta ntụkwasị obi nke na-emepụta ihe ọkụkụ, akụrụngwa ọgwụ na etiti.Hande eguzobela otu ọkachamara R&D ma nwee ụlọ ọrụ pilot GMP, nke nwere ike mee ka usoro azụmaahịa nke mmepụta na nyocha dịkwuo ngwa, na-agbakọ data usoro nke ihe nnwale, ma belata usoro mmepe.

  • API Mmepụta ọgwụ ọjọọ API

    API Mmepụta ọgwụ ọjọọ API

    Hande Bio bụ onye nrụpụta ntụkwasị obi nke na-emepụta ihe ọkụkụ, akụrụngwa ọgwụ na etiti.Hande eguzobela otu ọkachamara R&D ma nwee ụlọ ọrụ pilot GMP, nke nwere ike mee ka usoro azụmaahịa nke mmepụta na nyocha dịkwuo ngwa, na-agbakọ data usoro nke ihe nnwale, ma belata usoro mmepe.

  • Pharmaceutical API CDMO ụlọ ọrụ CDMO ọgwụ

    Pharmaceutical API CDMO ụlọ ọrụ CDMO ọgwụ

    Hande Bio bụ onye nrụpụta ntụkwasị obi nke na-emepụta ihe ọkụkụ, akụrụngwa ọgwụ na etiti.Hande eguzobela otu ọkachamara R&D ma nwee ụlọ ọrụ pilot GMP, nke nwere ike mee ka usoro azụmaahịa nke mmepụta na nyocha dịkwuo ngwa, na-agbakọ data usoro nke ihe nnwale, ma belata usoro mmepe.

  • Pharmaceutical API CDMO ahaziri R&D na ụlọ ọrụ mmepụta ihe

    Pharmaceutical API CDMO ahaziri R&D na ụlọ ọrụ mmepụta ihe

    Hande CDMO ọrụ maka ndị intermediates edebanyere aha na API, Hande Bio nwere 2 GMP mmepụta bases, nke izute Class A àgwà ọkọlọtọ mmepụta osisi, na melite a "3+1 ahaziri consulting otu" maka R & D, àgwà, mmepụta, na oru ngo consulting ka. ijikọ ọnụ chọta usoro mmepe ngwaahịa kacha mma.

  • Pharmaceutical API Ọrụ R&D ụlọ ọrụ ọrụ CRO

    Pharmaceutical API Ọrụ R&D ụlọ ọrụ ọrụ CRO

    Hande Bio, Na afọ 30 ọkachamara ndabere nke ihe ọkụkụ na API, anyị abụghị naanị ndị na-ebubata ngwaahịa mana ọpụrụiche na-enyere ụlọ ọrụ ọgwụ, ụlọ ọrụ ngwaọrụ ahụike, ụdị ahụike na ịma mma aka ịzụlite ngwaahịa ọhụrụ ha.

  • R&D ahaziri ahazi yana ọrụ mmepụta maka API ọgwụ na ndị etiti

    R&D ahaziri ahazi yana ọrụ mmepụta maka API ọgwụ na ndị etiti

    Hande Bio bụ onye nrụpụta ntụkwasị obi nke na-emepụta ihe ọkụkụ, akụrụngwa ọgwụ na etiti.Hande eguzobela otu ọkachamara R&D ma nwee ụlọ ọrụ pilot GMP, nke nwere ike mee ka usoro azụmaahịa nke mmepụta na nyocha dịkwuo ngwa, na-agbakọ data usoro nke ihe nnwale, ma belata usoro mmepe.

  • Ndị na-emepụta API ọgwụ R&D nke usoro API

    Ndị na-emepụta API ọgwụ R&D nke usoro API

    Hande Bio bụ onye nrụpụta ntụkwasị obi nke na-emepụta ihe ọkụkụ, akụrụngwa ọgwụ na etiti.Hande eguzobela otu ọkachamara R&D ma nwee ụlọ ọrụ pilot GMP, nke nwere ike mee ka usoro azụmaahịa nke mmepụta na nyocha dịkwuo ngwa, na-agbakọ data usoro nke ihe nnwale, ma belata usoro mmepe.

  • Pharma API biopharma CDMO

    Pharma API biopharma CDMO

    Hande Bio bụ onye nrụpụta ntụkwasị obi nke na-emepụta ihe ọkụkụ, akụrụngwa ọgwụ na etiti.Hande eguzobela otu ọkachamara R&D ma nwee ụlọ ọrụ pilot GMP, nke nwere ike mee ka usoro azụmaahịa nke mmepụta na nyocha dịkwuo ngwa, na-agbakọ data usoro nke ihe nnwale, ma belata usoro mmepe.

  • Ọrụ CDMO maka ndị etiti na API ndị edebanyere aha

    Ọrụ CDMO maka ndị etiti na API ndị edebanyere aha

    Hande CDMO ọrụ maka ndị intermediates edebanyere aha na API, Hande Bio nwere 2 GMP mmepụta bases, nke izute Class A àgwà ọkọlọtọ mmepụta osisi, na melite a "3+1 ahaziri consulting otu" maka R & D, àgwà, mmepụta, na oru ngo consulting ka. ijikọ ọnụ chọta usoro mmepe ngwaahịa kacha mma.

  • Ọrụ nrụpụta API-Custom-Custom

    Ọrụ nrụpụta API-Custom-Custom

    Hande Bio, Na afọ 30 ọkachamara ndabere nke ihe ọkụkụ na API, anyị abụghị naanị ndị na-ebubata ngwaahịa mana ọpụrụiche na-enyere ụlọ ọrụ ọgwụ, ụlọ ọrụ ngwaọrụ ahụike, ụdị ahụike na ịma mma aka ịzụlite ngwaahịa ọhụrụ ha.

  • Ọrụ nrụpụta API omenala

    Ọrụ nrụpụta API omenala

    Hande Bio bụ onye nrụpụta ntụkwasị obi nke na-emepụta ihe ọkụkụ, akụrụngwa ọgwụ na etiti.Hande eguzobela otu ọkachamara R&D ma nwee ụlọ ọrụ pilot GMP, nke nwere ike mee ka usoro azụmaahịa nke mmepụta na nyocha dịkwuo ngwa, na-agbakọ data usoro nke ihe nnwale, ma belata usoro mmepe.

  • Ọrụ CDMO API ọgwụ

    Ọrụ CDMO API ọgwụ

    Hande Bio bụ onye nrụpụta ntụkwasị obi nke na-emepụta ihe ọkụkụ, akụrụngwa ọgwụ na etiti.Hande eguzobela otu ọkachamara R&D ma nwee ụlọ ọrụ pilot GMP, nke nwere ike mee ka usoro azụmaahịa nke mmepụta na nyocha dịkwuo ngwa, na-agbakọ data usoro nke ihe nnwale, ma belata usoro mmepe.